Ontology highlight
ABSTRACT: Background
OL-FS13, a neuroprotective peptide derived from Odorrana livida, can alleviate cerebral ischemia-reperfusion (CI/R) injury, although the specific underlying mechanism remains to be further explored.Objective
The effect of miR-21-3p on the neural-protective effects of OL-FS13 was examined.Methods
In this study, the multiple genome sequencing analysis, double luciferase experiment, RT-qPCR, and Western blotting were used to explore the mechanism of OL-FS13.Results
Showed that over-expression of miR-21-3p against the protective effects of OL-FS13 on oxygen- glucose deprivation/re-oxygenation (OGD/R)-damaged pheochromocytoma (PC12) cells and in CI/R-injured rats. miR-21-3p was then found to target calcium/calmodulin-dependent protein kinase 2 (CAMKK2), and its overexpression inhibited the expression of CAMKK2 and phosphorylation of its downstream adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK), thereby inhibiting the therapeutic effects of OL-FS13 on OGD/R and CI/R. Inhibition of CAMKK2 also antagonized up-regulated of nuclear factor erythroid 2-related factor 2 (Nrf-2) by OL-FS13, thereby abolishing the antioxidant activity of the peptide.Conclusion
Our results showed that OL-FS13 alleviated OGD/R and CI/R by inhibiting miR-21-3p to activate the CAMKK2/AMPK/Nrf-2 axis.
SUBMITTER: Liu N
PROVIDER: S-EPMC10616927 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature

Liu Naixin N Fan Yan Y Li Yilin Y Zhang Yingxuan Y Li Jiayi J Wang Yinglei Y Wang Zhuo Z Liu Yixiang Y Li Yuansheng Y Kang Zijian Z Peng Ying Y Ru Zeqiong Z Yang Meifeng M Feng Chengan C Wang Ying Y Yang Xinwang X
Current neuropharmacology 20230101 12
<h4>Background</h4>OL-FS13, a neuroprotective peptide derived from Odorrana livida, can alleviate cerebral ischemia-reperfusion (CI/R) injury, although the specific underlying mechanism remains to be further explored.<h4>Objective</h4>The effect of miR-21-3p on the neural-protective effects of OL-FS13 was examined.<h4>Methods</h4>In this study, the multiple genome sequencing analysis, double luciferase experiment, RT-qPCR, and Western blotting were used to explore the mechanism of OL-FS13.<h4>Re ...[more]